{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T20:32:00Z","timestamp":1781901120731,"version":"3.54.5"},"reference-count":115,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Government of the Russian Federation","award":["14.W03.31.0009"],"award-info":[{"award-number":["14.W03.31.0009"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.autrev.2020.102496","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T11:58:37Z","timestamp":1581595117000},"page":"102496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Polymorphism of toll-like receptor genes and autoimmune endocrine diseases"],"prefix":"10.1016","volume":"19","author":[{"given":"Kristina A.","family":"Dvornikova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Y.","family":"Bystrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga N.","family":"Platonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid P.","family":"Churilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2020.102496_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8473-z","article-title":"Toll-like receptor pathways in autoimmune diseases","volume":"50","author":"Chen","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"139","key":"10.1016\/j.autrev.2020.102496_bb0010","first-page":"1","article-title":"The autoimmune ecology","volume":"7","author":"Anaya","year":"2016","journal-title":"Front Immunol"},{"issue":"382","key":"10.1016\/j.autrev.2020.102496_bb0015","first-page":"1","article-title":"Toll-like receptor (TLR) and nucleosome-binding oligomerization domain (NOD) gene polymorphisms and endometrial cancer risk","volume":"10","author":"Ashton","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.autrev.2020.102496_bb0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/gene.2014.10","article-title":"Relevance of single-nucleotide polymorphisms in human TLR genes to infectious and inflammatory diseases and cancer","volume":"15","author":"Trejo-de la","year":"2014","journal-title":"Genes Immun"},{"key":"10.1016\/j.autrev.2020.102496_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2018.03.002","article-title":"Toll-like receptors in immunity and inflammatory diseases: past, present, and future","volume":"59","author":"Vijay","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2020.102496_bb0030","first-page":"1","article-title":"The role of toll-like receptors in autoimmune diseases through failure of the self-recognition mechanism","author":"Farrugia","year":"2017","journal-title":"Int J Inflamm"},{"key":"10.1016\/j.autrev.2020.102496_bb0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/ITT.S89795","article-title":"Toll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developments","volume":"5","author":"O'Reilly","year":"2016","journal-title":"Immuno Targets Ther"},{"issue":"2","key":"10.1016\/j.autrev.2020.102496_bb0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.smim.2011.01.016","article-title":"Toll-like receptor driven B cell activation in the induction of systemic autoimmunity","volume":"23","author":"Green","year":"2011","journal-title":"Semin Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102496_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2015.08.009","article-title":"The critical role of toll-like receptors - from microbial recognition to autoimmunity: a comprehensive review","volume":"15","author":"Jim\u00e9nez-Dalmaroni","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2020.102496_bb0050","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.autrev.2018.10.005","article-title":"Innate immune-responses and their role in driving autoimmunity","volume":"18","author":"Toubi","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102496_bb0055","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bbr.2016.08.047","article-title":"TLR4 is a link between diabetes and Alzheimer's disease","volume":"316","author":"Huang","year":"2017","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.autrev.2020.102496_bb0060","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaut.2018.10.012","article-title":"Molecular mimicry and autoimmunity","volume":"95","author":"Rojas","year":"2018","journal-title":"J Autoimmun"},{"issue":"7450","key":"10.1016\/j.autrev.2020.102496_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/nature12118","article-title":"The TLR4 antagonist Eritoran protects mice from lethal influenza infection","volume":"497","author":"Shirey","year":"2013","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.autrev.2020.102496_bb0070","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1016\/j.vaccine.2010.08.002","article-title":"TLR-based immune adjuvants","volume":"29","author":"Steinhagen","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.autrev.2020.102496_bb0075","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/jir.2012.0140","article-title":"Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and Cancer","volume":"33","author":"Medvedev","year":"2013","journal-title":"J Interferon Cytokine Res"},{"issue":"1","key":"10.1016\/j.autrev.2020.102496_bb0080","doi-asserted-by":"crossref","first-page":"605","DOI":"10.15171\/apb.2015.082","article-title":"Toll-like receptors in the pathogenesis of autoimmune diseases","volume":"5","author":"Mohammad Hosseini","year":"2015","journal-title":"Adv Pharm Bull"},{"issue":"6","key":"10.1016\/j.autrev.2020.102496_bb0085","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.autrev.2018.12.010","article-title":"Emerging role of air pollution in autoimmune diseases","volume":"18","author":"Zhao","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2020.102496_bb0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.autrev.2016.12.003","article-title":"TLRs, future potential therapeutic targets for RA","volume":"16","author":"Elshabrawy Hatem","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"140","key":"10.1016\/j.autrev.2020.102496_bb0095","first-page":"299","article-title":"Re-framing the theory of autoimmunity in the era of the microbiome: persistent pathogens, autoantibodies, and molecular mimicry","volume":"25","author":"Proal","year":"2018","journal-title":"Discov Med"},{"issue":"11","key":"10.1016\/j.autrev.2020.102496_bb0100","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.autrev.2015.07.006","article-title":"Gene\/environment interactions in the pathogenesis of autoimmunity: new insights on the role of toll-like receptors","volume":"14","author":"Gianchecchi","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.autrev.2020.102496_bb0105","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.autrev.2018.05.013","article-title":"Celiac disease and endocrine autoimmunity - the genetic link","volume":"17","author":"Kahaly","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102496_bb0110","series-title":"Immunoendocrinology: scientific and clinical aspects","first-page":"251","article-title":"Genetics of type 1 diabetes","author":"Michels","year":"2011"},{"key":"10.1016\/j.autrev.2020.102496_bb0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jaut.2017.09.012","article-title":"Risk of beta-cell autoimmunity presence for progression to type 1 diabetes: a systematic review and meta-analysis","volume":"86","author":"Ling","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102496_bb0120","series-title":"Immunoendocrinology: scientific and clinical aspects","first-page":"267","article-title":"Epidemiology of type 1 diabetes","author":"Molly","year":"2011"},{"issue":"7","key":"10.1016\/j.autrev.2020.102496_bb0125","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.autrev.2016.02.017","article-title":"Type 1 diabetes associated autoimmunity","volume":"15","author":"Kahaly","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2020.102496_bb0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/dme.12099","article-title":"The environment and the origins of islet autoimmunity and type 1 diabetes","volume":"30","author":"Eringsmark Regn\u00e9ll","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/j.autrev.2020.102496_bb0135","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.coph.2019.04.018","article-title":"Autoimmunity in microbiome-mediated diseases and novel therapeutic approaches","volume":"49","author":"Shin","year":"2019","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.autrev.2020.102496_bb0140","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/gutjnl-2017-314508","article-title":"Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice","volume":"67","author":"Hanninen","year":"2018","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.autrev.2020.102496_bb0145","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/ni.3713","article-title":"Gut microbial metabolites limit the frequency of autoimmune T-cells and protect against type 1 diabetes","volume":"18","author":"Marino","year":"2017","journal-title":"Nat Immunol"},{"issue":"40","key":"10.1016\/j.autrev.2020.102496_bb0150","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.1073\/pnas.1711235114","article-title":"Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models","volume":"114","author":"Cekanaviciute","year":"2017","journal-title":"Proc Natl Acad Sci"},{"issue":"40","key":"10.1016\/j.autrev.2020.102496_bb0155","doi-asserted-by":"crossref","first-page":"10719","DOI":"10.1073\/pnas.1711233114","article-title":"Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice","volume":"114","author":"Berer","year":"2017","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"10.1016\/j.autrev.2020.102496_bb0160","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.autrev.2019.03.016","article-title":"The gut microbiota perspective for interventions in MS","volume":"18","author":"Zoledziewska","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102496_bb0165","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/s41591-018-0164-x","article-title":"Regional variation limits applications of healthy gut microbiome reference ranges and disease models","volume":"24","author":"He","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2020.102496_bb0170","first-page":"212","article-title":"Untangling narcolepsy and diabetes: pathomechanisms with eyes on therapeutic options","volume":"2019","author":"Mohammadi","year":"1718","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.autrev.2020.102496_bb0175","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/BOR.0b013e3283533719","article-title":"vonHerrath MG. (2012). Infection as a cause of type 1 diabetes?","volume":"24","author":"Christen","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102496_bb0180","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.2337\/db14-1370","article-title":"Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes","volume":"64","author":"Krogvold","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.autrev.2020.102496_bb0185","doi-asserted-by":"crossref","first-page":"102301","DOI":"10.1016\/j.jaut.2019.06.012","article-title":"Bystander activation and autoimmunity","volume":"103","author":"Pacheco","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102496_bb0190","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/apm.12011","article-title":"Viral infections and molecular mimicry in type 1 diabetes","volume":"120","author":"Coppieters","year":"2012","journal-title":"APMIS"},{"key":"10.1016\/j.autrev.2020.102496_bb0195","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2016.03.006","article-title":"The role of the innate immune system in destruction of pancreatic beta cells in NOD mice and humans with type I diabetes","volume":"71","author":"Tai","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102496_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/8475341","article-title":"The coincidence of newly diagnosed type 1 diabetes mellitus with IgM antibody positivity to enteroviruses and respiratory tract viruses","author":"Karaoglan","year":"2018","journal-title":"J Diabetes Res"},{"issue":"1","key":"10.1016\/j.autrev.2020.102496_bb0205","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1196\/annals.1337.028","article-title":"Association of the polymorphism for toll-like receptor 2 with type 1 diabetes susceptibility","volume":"1037","author":"Park","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.autrev.2020.102496_bb0210","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1399-0039.2005.00454.x","article-title":"Toll-like receptor 3 gene polymorphisms in South African blacks with type 1 diabetes","volume":"66","author":"Pirie","year":"2005","journal-title":"Tissue Antigens"},{"issue":"2","key":"10.1016\/j.autrev.2020.102496_bb0215","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/gene.2008.100","article-title":"A TLR2 polymorphism is associated with type 1 diabetes and allergic asthma","volume":"10","author":"Bj\u00f8rnvold","year":"2009","journal-title":"Genes Immun"},{"issue":"11","key":"10.1016\/j.autrev.2020.102496_bb0220","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.humimm.2014.09.008","article-title":"SNPs in the exons of toll-like receptors are associated with susceptibility to type 1 diabetes in Chinese population","volume":"75","author":"Sun","year":"2014","journal-title":"Hum Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102496_bb0225","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1530\/EJE-13-0963","article-title":"Polymorphisms in the TLR3 gene are associated with risk for type 1 diabetes mellitus","volume":"170","author":"Assmann","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.autrev.2020.102496_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3023","article-title":"Genetic differences between type 1 diabetes with and without other autoimmune diseases","volume":"34","author":"Shimura","year":"2018","journal-title":"Diabetes\/Metab Res Rev"},{"key":"10.1016\/j.autrev.2020.102496_bb0235","first-page":"4","article-title":"Association of PTPN22 gene polymorphism with type 1 diabetes mellitus in various populations of the Russian Federation","volume":"2","author":"Ivanova","year":"2013","journal-title":"Diabet [Diabetes]"},{"key":"10.1016\/j.autrev.2020.102496_bb0240","doi-asserted-by":"crossref","first-page":"100005","DOI":"10.1016\/j.jtauto.2019.100005","article-title":"Identification and characterization of rare toll-like receptor 3 variants in patients with autoimmune Addison's disease","volume":"1","author":"Aslaksen","year":"2019","journal-title":"J Transl Autoimmun"},{"issue":"1","key":"10.1016\/j.autrev.2020.102496_bb0245","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00005-015-0360-z","article-title":"Polymorphisms of the toll-like receptor-3 gene in autoimmune adrenal failure and type 1 diabetes in polish patients","volume":"64","author":"Fichna","year":"2015","journal-title":"Arch Immunol et Ther Exp"},{"issue":"4","key":"10.1016\/j.autrev.2020.102496_bb0250","first-page":"282","article-title":"Urbanization-related factors of the incidence of Type I diabetes mellitus","volume":"10","author":"Soprun","year":"2018","journal-title":"Biosfera [Biosphere]"},{"key":"10.1016\/j.autrev.2020.102496_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2017.10.041","article-title":"Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study","volume":"141","author":"Barzaghi","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2020.102496_bb0260","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nyas.13011","article-title":"From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation","volume":"1417","author":"Bacchetta","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2020.102496_bb0265","doi-asserted-by":"crossref","DOI":"10.1177\/2333794X19845074","article-title":"A rare case of autoimmune polyglandular syndrome type 2 in a child with persistent fatigue","volume":"6","author":"Smith","year":"2019","journal-title":"Global Pediatric Health"},{"key":"10.1016\/j.autrev.2020.102496_bb0270","first-page":"636","article-title":"Thyroid autoimmunity","volume":"4","author":"Feldt-Rasmussen","year":"2018","journal-title":"Ref Modul Biomed Sci"},{"issue":"1","key":"10.1016\/j.autrev.2020.102496_bb0275","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s13317-013-0055-6","article-title":"A rare combination of type 3 autoimmune polyendocrine syndrome (APS-3) or multiple autoimmune syndrome (MAS-3)","volume":"5","author":"Betterle","year":"2014","journal-title":"Autoimmun Highlights"},{"key":"10.1016\/j.autrev.2020.102496_bb0280","series-title":"The genetics of diabetes mellitus","first-page":"1","article-title":"Diabetes mellitus: A geneticist's nightmare","author":"Neel","year":"1976"},{"key":"10.1016\/j.autrev.2020.102496_bb0285","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaut.2017.12.001","article-title":"Activation of thyroid antigen-reactive B cells in recent onset autoimmune thyroid disease patients","volume":"89","author":"Smith","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102496_bb0290","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3343\/alm.2019.39.1.3","article-title":"Laboratory testing in thyroid conditions: pitfalls and clinical utility","volume":"39","author":"Soh","year":"2019","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.autrev.2020.102496_bb0295","series-title":"Mosaic of autoimmunity. The novel factors of autoimmune diseases","first-page":"155","article-title":"Laboratory diagnostics","author":"Bizzaro","year":"2019"},{"issue":"2\u20133","key":"10.1016\/j.autrev.2020.102496_bb0300","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jaut.2011.12.001","article-title":"Sex differences and genomics in autoimmune diseases","volume":"38","author":"Amur","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102496_bb0305","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/bs.vh.2017.07.001","article-title":"Thyroid autoimmunity: an interplay of factors","volume":"106","author":"Merrill","year":"2018","journal-title":"Vitam Horm"},{"issue":"11","key":"10.1016\/j.autrev.2020.102496_bb0310","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.4049\/jimmunol.1203412","article-title":"Yersinia enterocolitica provides the link between thyroid-stimulating antibodies and their germline counterparts in graves'disease","volume":"190","author":"Hargreaves","year":"2013","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2020.102496_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110878","article-title":"Effects of latent toxoplasmosis on autoimmune thyroid diseases in pregnancy","volume":"9","author":"Ka\u0148kov\u00e1","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102496_bb0320","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.autrev.2008.07.013","article-title":"Infections and autoimmune thyroid diseases: parallel detection of antibodies against pathogens with proteomic technology","volume":"8","author":"Tozzoli","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102496_bb0325","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.humimm.2014.05.001","article-title":"Association of TLR4 and TLR5 gene polymorphisms with Graves' disease in Chinese Cantonese population","volume":"75","author":"Xiao","year":"2014","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2020.102496_bb0330","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1471-2350-11-154","article-title":"Toll-like receptor gene polymorphisms are associated with susceptibility to Graves' ophthalmopathy in Taiwan males","volume":"11","author":"Liao","year":"2010","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.autrev.2020.102496_bb0335","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/08916934.2014.939269","article-title":"Polymorphisms in TLR1, TLR6 and TLR10 genes and the risk of Graves' disease","volume":"48","author":"Xiao","year":"2014","journal-title":"Autoimmun"},{"key":"10.1016\/j.autrev.2020.102496_bb0340","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/tan.12479","article-title":"Association of Toll-like receptor 7 and 8 gene polymorphisms with Graves' disease in Chinese Cantonese population","volume":"85","author":"Xiao","year":"2015","journal-title":"Tissue Antigens"},{"issue":"1","key":"10.1016\/j.autrev.2020.102496_bb0345","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev-pathol-012513-104713","article-title":"Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics","volume":"9","author":"Tomer","year":"2014","journal-title":"Ann Rev Pathol: Mech Dis"},{"issue":"1","key":"10.1016\/j.autrev.2020.102496_bb0350","doi-asserted-by":"crossref","first-page":"E144","DOI":"10.1210\/jc.2012-2408","article-title":"Fine mapping of loci linked to autoimmune thyroid disease identifies novel susceptibility genes","volume":"98","author":"Tomer","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2020.102496_bb0355","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mce.2010.01.013","article-title":"Genetics of thyroid autoimmunity and the role of TSHR","volume":"322","author":"Brand","year":"2010","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"10.1016\/j.autrev.2020.102496_bb0360","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1210\/en.2010-0321","article-title":"Antibodies to thyroid peroxidase arise spontaneously with age in NOD.H-2h4 mice and appear after thyroglobulin antibodies","volume":"151","author":"Chen","year":"2010","journal-title":"Endocrinol"},{"issue":"36","key":"10.1016\/j.autrev.2020.102496_bb0365","doi-asserted-by":"crossref","first-page":"31168","DOI":"10.1074\/jbc.M111.247510","article-title":"Novel variant of thyroglobulin promoter triggers thyroid autoimmunity through an epigenetic interferon \u03b1-modulated mechanism","volume":"286","author":"Stefan","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102496_bb0370","doi-asserted-by":"crossref","first-page":"102333","DOI":"10.1016\/j.jaut.2019.102333","article-title":"Immune checkpoint molecules. Possible future therapeutic implications in autoimmune diseases","volume":"104","author":"Huang","year":"2019","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.autrev.2020.102496_bb0375","doi-asserted-by":"crossref","first-page":"10074","DOI":"10.1038\/s41598-018-28423-9","article-title":"CTLA-4 +49G\/A, a functional T1D risk SNP, affects CTLA-4 level in Treg subsets and IA-2A positivity, but not beta-cell function","volume":"8","author":"Chen","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.autrev.2020.102496_bb0380","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2478\/folmed-2018-0078","article-title":"Zer\u00f3n HM genetics of thyroid disorders","volume":"61","author":"Cort\u00e9s","year":"2019","journal-title":"Folia Med"},{"issue":"3","key":"10.1016\/j.autrev.2020.102496_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059349","article-title":"Association between age at diagnosis of Graves'disease and variants in genes involved in immune response","volume":"8","author":"Jurecka-Lubieniecka","year":"2013","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.autrev.2020.102496_bb0390","article-title":"Association between CTLA-4 gene polymorphism and myasthenia gravis in a Chinese cohort","volume":"S0967-5868","author":"Cai","year":"2019","journal-title":"J Clin Neurosci"},{"issue":"1","key":"10.1016\/j.autrev.2020.102496_bb0395","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12020-016-1096-1","article-title":"CD28\/CTLA-4\/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease","volume":"55","author":"Pawlak-Adamska","year":"2016","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.autrev.2020.102496_bb0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154394","article-title":"Association of cytotoxic T-lymphocyte-associated protein 4 (CTLA4) gene polymorphisms with autoimmune thyroid disease in children and adults: case-control study","volume":"11","author":"Ting","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102496_bb0405","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-019-0360-0","article-title":"Depletion of PD-1-positive cells ameliorates autoimmune disease","volume":"3","author":"Zhao","year":"2019","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.autrev.2020.102496_bb0410","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ebiom.2018.09.040","article-title":"PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-\u03b1 and-\u03b3 via IRF1 induction","volume":"36","author":"Colli","year":"2018","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.autrev.2020.102496_bb0415","doi-asserted-by":"crossref","first-page":"39105","DOI":"10.1038\/srep39105","article-title":"Endogenous programmed death ligand-1 restrains the development and onset of Sj\u04e7gren's syndrome in non-obese diabetic mice","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.autrev.2020.102496_bb0420","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.rdc.2017.09.008","article-title":"Rheumatic manifestations in autoimmune liver disease","volume":"44","author":"Selmi","year":"2018","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2020.102496_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2018.10.014","article-title":"Extrahepatic autoimmunity in autoimmune liver disease","volume":"59","author":"Floreani","year":"2018","journal-title":"Eur J Intern Med"},{"issue":"6","key":"10.1016\/j.autrev.2020.102496_bb0430","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.4049\/jimmunol.1200311","article-title":"Genetically driven target tissue overexpression of CD40: anovel mechanism in autoimmune disease","volume":"189","author":"Huber","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102496_bb0435","first-page":"10","article-title":"Association between the CD40 rs1883832 polymorphism and Graves' disease risk: a meta-analysis","volume":"18","author":"Wang","year":"2019","journal-title":"EXCLI J"},{"key":"10.1016\/j.autrev.2020.102496_bb0440","first-page":"1","article-title":"Disturbances of modulating molecules (FOXP3, CTLA-4\/CD28\/B7, and CD40\/CD40L) mRNA expressions in the orbital tissue from patients with severe graves' ophthalmopathy","author":"Pawlowski","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"12","key":"10.1016\/j.autrev.2020.102496_bb0445","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1089\/thy.2016.0243","article-title":"Thyrotropin and CD40L stimulate interleukin-12 expression in fibrocytes: implications for pathogenesis of thyroid-associated ophthalmopathy","volume":"26","author":"Wu","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.autrev.2020.102496_bb0450","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.2147\/OPTH.S88444","article-title":"Does autoimmunity against thyroglobulin play a role in the pathogenesis of Graves' ophthalmopathy: a review","volume":"9","author":"Wall","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.autrev.2020.102496_bb0455","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders","volume":"14","author":"Antonelli","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.autrev.2020.102496_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07420528.2019.1642909","article-title":"Clock gene PERIOD3 polymorphism is associated with susceptibility to Graves' disease but not to Hashimoto's thyroiditis","volume":"36","author":"Helvaci","year":"2019","journal-title":"Chronobiol Int"},{"issue":"1","key":"10.1016\/j.autrev.2020.102496_bb0465","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PPO.0000000000000296","article-title":"Toxicities associated with PD-1\/PD-L1 blockade","volume":"24","author":"Wang","year":"2018","journal-title":"Cancer J"},{"issue":"12","key":"10.1016\/j.autrev.2020.102496_bb0470","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/jamaoncol.2018.3923","article-title":"Fatal toxic effects associated with immune checkpoint inhibitors","volume":"4","author":"Wang","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.autrev.2020.102496_bb0475","article-title":"Thyroid autoimmune disorders and cancer","author":"Ferrari","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.autrev.2020.102496_bb0480","article-title":"Autoimmune diseases and hematological malignancies: exploring the underlying mechanisms from epidemiological evidence","author":"Hemminki","year":"2019","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"10.1016\/j.autrev.2020.102496_bb0485","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2337\/dc18-0288","article-title":"Identical and nonidentical twins: risk and factors involved in development of islet autoimmunity and type 1 diabetes","volume":"42","author":"Triolo","year":"2018","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.autrev.2020.102496_bb0490","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.2741\/4265","article-title":"TNF \/ TNFR: drug target for autoimmune diseases and immune-mediated inflammatory diseases","volume":"19","author":"Doss","year":"2014","journal-title":"Front Biosci"},{"key":"10.1016\/j.autrev.2020.102496_bb0495","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.oraloncology.2018.08.015","article-title":"Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: a systematic review","volume":"85","author":"Saka","year":"2018","journal-title":"Oral Oncol"},{"issue":"8","key":"10.1016\/j.autrev.2020.102496_bb0500","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.3390\/ijms19082332","article-title":"Clinically relevant anti-inflammatory agents for chemoprevention of colorectal cancer: new perspectives","volume":"19","author":"Mohammed","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2020.102496_bb0505","article-title":"Editorial. Autoimmune disease and cancer comorbidity: current understandings of immune-mediated pathogenesis and treatment","author":"Islam","year":"2019","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.autrev.2020.102496_bb0510","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s11102-015-0699-5","article-title":"Prevalence of autoimmune disease in patients with prolactinomas and non-functioning pituitary adenomas","volume":"19","author":"Larouche","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.autrev.2020.102496_bb0515","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12020-012-9703-2","article-title":"The incidence and prevalence of thyroid autoimmunity","volume":"42","author":"McLeod","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.autrev.2020.102496_bb0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2016.09.007","article-title":"Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes","volume":"76","author":"Li","year":"2017","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.autrev.2020.102496_bb0525","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1089\/thy.2014.0135","article-title":"Association of toll-like receptor 10 polymorphisms with autoimmune thyroid disease in Korean children","volume":"25","author":"Cho","year":"2015","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.autrev.2020.102496_bb0530","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1080\/08916934.2016.1261835","article-title":"Polymorphisms and expression of toll-like receptors in autoimmune thyroid diseases","volume":"50","author":"Inoue","year":"2016","journal-title":"Autoimmun"},{"key":"10.1016\/j.autrev.2020.102496_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/2304218","article-title":"Association of polymorphisms in toll-like receptors 4 and 9 with autoimmune thyroid disease in Korean pediatric patients","author":"Cho","year":"2017","journal-title":"Int J Endocrinol"},{"issue":"4","key":"10.1016\/j.autrev.2020.102496_bb0540","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ygeno.2018.04.012","article-title":"Genome-wide meta-analysis identifies novel gender specific loci associated with thyroid antibodies level in croatians","volume":"111","author":"Matana","year":"2018","journal-title":"Genom"},{"issue":"521","key":"10.1016\/j.autrev.2020.102496_bb0545","first-page":"1","article-title":"Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases","volume":"8","author":"Fr\u00f6hlich","year":"2017","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2020.102496_bb0550","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002293","article-title":"A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci","volume":"7","author":"Bradfield","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.autrev.2020.102496_bb0555","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mce.2018.10.017","article-title":"CEP128 is a crucial risk locus for autoimmune thyroid diseases","volume":"480","author":"Wang","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.autrev.2020.102496_bb0560","article-title":"Higher levels of serum TLR2 and TLR4 in patients with Hashimoto's thyroiditis","volume":"19","author":"Akta\u015f","year":"2019","journal-title":"J:Endocr Metab Immune Disord - Drug Targets"},{"key":"10.1016\/j.autrev.2020.102496_bb0565","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.2147\/OPTH.S87972","article-title":"Novel single-nucleotide polymorphisms in the calsequestrin-1 gene are associated with Graves' ophthalmopathy and Hashimoto's thyroiditis","volume":"9","author":"Lahooti","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.autrev.2020.102496_bb0570","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2147\/OPTH.S136070","article-title":"Single nucleotide polymorphism 1623 A\/G (rs180195) in the promoter of the thyroglobulin gene is associated with autoimmune thyroid disease but not with thyroid ophthalmopathy","volume":"11","author":"Lahooti","year":"2017","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.autrev.2020.102496_bb0575","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1210\/me.2004-0100","article-title":"Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto's autoimmune thyroiditis","volume":"19","author":"Harii","year":"2005","journal-title":"Mol Endocrinol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220300446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220300446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:17:08Z","timestamp":1761599828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997220300446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":115,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1568997220300446"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102496","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymorphism of toll-like receptor genes and autoimmune endocrine diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102496"}}